The Effect of Transcranial Direct Current Stimulation (tDCS) on Motor and Cognitive Functions in Idiopathic Fallers
1 other identifier
interventional
40
2 countries
2
Brief Summary
The concurrent performance of two tasks, i.e., dual tasking (DT), is a common and ubiquitous every day phenomena. For example, people frequently walk while talking on a cellphone or drive while talking to a passenger. Often, the performance of one or more of these simultaneously performed tasks may deteriorate when another task is carried out at the same time, even in healthy young adults. This reduction in performance is referred to as the DT deficit or DT cost and is typically much higher in Idiopathic Fallers (IF) than in age-matched controls. In this population the DT cost impairs the gait pattern, as manifested, for example, in increased gait variability, exacerbating instability and fall risk. In the proposed study, would be evaluated the effects of tDCS on dual tasking performance following tDCS. The researchers expect that stimulation of the Pre Frontal Cortex (PFC) (using tDCS) will increase DT performance and prefrontal activation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2016
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedFirst Posted
Study publicly available on registry
November 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedApril 21, 2017
April 1, 2017
1.1 years
October 31, 2016
April 20, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Immediate change in gait speed
Gait speed will be assessed under usual and dual task conditions and while negotiating physical obstacles, using a sensorized 7 meter carpet (PKMAS) and wearable body fixed sensors. These measures will be compared to baseline performance.
1st measure will be taken at baseline ans 2nd immediate post intervention
Secondary Outcomes (2)
fNIRS related frontal lobe activation - changes in tissue oxygenation
1st measure will be taken at baseline ans 2nd immediate post intervention
Changes in cognitive performance - Executive Function composite score
1st measure will be taken at baseline ans 2nd immediate post intervention
Study Arms (1)
tDCS
EXPERIMENTALThe active tDCS condition will consist of 4 visit: During each visit, subject will receive a single 20-minute session targeting the prefrontal cortices of either real (1.5 mA) or sham tDCS. Total 4 different targets: 1. Sham 2. motor M1 area 3. motor M1 + Dorsolateral Prefrontal cortex 4. Dorsolateral Prefrontal cortex. The tDCS condition will be randomized and double blinded
Interventions
The active tDCS condition will consist of 20 min of continuous stimulation. This amount of stimulation is safe for healthy young and older adults and has been shown to induce acute beneficial changes in cortical excitability and cognitive functions.
Eligibility Criteria
You may qualify if:
- age 65-85 years,
- ability to walk for 6 minutes unassisted,
- adequate vision capabilities, and
- stable medications for the past month.
You may not qualify if:
- diagnosis of stroke, Parkinson's disease, peripheral neuropathy or other neurologic disorder,
- lower-extremity deformity, joint replacement, severe arthritis or other diagnosed musculoskeletal disorder that may influence gait,
- orthostatic hypotension, recent history of syncope or vertigo,
- myocardial infarction or surgery within the past 6 months,
- any unstable medical condition,
- psychiatric co-morbidity (e.g., major depressive disorder as determined by DSM V criteria),
- likely dementia (i.e., Mini Mental State Exam score \< 24 or based on DSM V),
- sedating medications (sedatives, anti-psychotics, hypnotics, anti-depressants,
- colorblindness (confounder for cognitive assessment), or
- contraindications to tDCS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hebrew Rehabilitation Center / Harvard Medical School
Roslindale, Massachusetts, 02121, United States
Laboratory for Gait and Neurodynamics, Tel Aviv Sourasky Medical Center
Tel Aviv, 64239, Israel
Related Publications (2)
Zhou J, Hao Y, Wang Y, Jor'dan A, Pascual-Leone A, Zhang J, Fang J, Manor B. Transcranial direct current stimulation reduces the cost of performing a cognitive task on gait and postural control. Eur J Neurosci. 2014 Apr;39(8):1343-8. doi: 10.1111/ejn.12492. Epub 2014 Jan 20.
PMID: 24443958RESULTSchneider N, Dagan M, Katz R, Thumm PC, Brozgol M, Giladi N, Manor B, Mirelman A, Hausdorff JM. Combining transcranial direct current stimulation with a motor-cognitive task: the impact on dual-task walking costs in older adults. J Neuroeng Rehabil. 2021 Feb 1;18(1):23. doi: 10.1186/s12984-021-00826-2.
PMID: 33526043DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nir Giladi, Prof.
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Research and Development
Study Record Dates
First Submitted
October 31, 2016
First Posted
November 3, 2016
Study Start
November 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
April 21, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share